Skip to content

Diagnostic Accuracy of Shear-Wave Elastography for the Preoperative Risk Stratification of Follicular Lesions of the Thyroid

A Multivariate Analysis of Factors Predictive of Carcinoma in Follicular Neoplasms of the Thyroid Gland

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03106337
Enrollment
35
Registered
2017-04-10
Start date
2010-01-31
Completion date
2012-04-30
Last updated
2017-05-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Follicular Neoplasm, Thyroid Nodule

Keywords

Thyroid, Follicular Neoplasms, Bethesda System, Elastography, Doppler ultrasound, Thyroidectomy

Brief summary

As many as 70-85% subjects diagnosed with a follicular lesion on biopsy and undergoing surgery will have benign lesions verified by histopathology after surgery. Currently there is no method of pre-operatively diagnosing benign follicular lesions, as a result these subjects will have had surgery for diagnosis of a benign lesion. The aim of this study is to see whether shear-wave elastography, a new ultrasound technology can help pre-operatively diagnose benign follicular lesions. If successful, a lot of patients will not need surgery for the diagnosis of a benign lesion. The main goal of this study will be to evaluate the diagnostic accuracy of a new ultrasound technology, shear-wave elastography (SWE), for the diagnosis of malignancy in follicular lesions. Participants who have been diagnosed with a follicular lesion on thyroid biopsy and are scheduled for thyroid surgery will be eligible to participate. All participants will undergo a detailed ultrasound examination prior to their surgery. The results of the ultrasound will be compared with histopathology after surgery to test the diagnostic accuracy of SWE.

Interventions

Shear-Wave Elastography was performed on patients scheduled for partial/total thyroidectomy. Results were compared with pathology from surgical excision.

Sponsors

Massachusetts General Hospital
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients diagnosed with a Follicular Neoplasm on fine needle aspiration biopsy * Patients \>18 years of age

Exclusion criteria

* None

Design outcomes

Primary

MeasureTime frameDescription
Shear-Wave Elastography (SWE) Values in kiloPascals (kPa)Baseline (Day 0)Elastography provides a quantitative score of thyroid nodule stiffness that is expected to correlate with the biological nature of the nodule. Mean SWE values, in three planes: traverse plane, sagittal plane and transverse plane with nodule in the center, of all benign lesions were compared with mean SWE values of all malignant lesions on histopathology obtained post surgery.

Countries

United States

Participant flow

Participants by arm

ArmCount
Shear-Wave Elastography
Shear-Wave Elastography was performed on patients scheduled for partial/total thyroidectomy. Results were compared with pathology from surgical excision.
35
Total35

Baseline characteristics

CharacteristicShear-Wave Elastography
Age, Continuous55 years
STANDARD_DEVIATION 16.1
Region of Enrollment
United States
35 participants
Sex: Female, Male
Female
23 Participants
Sex: Female, Male
Male
12 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
— / —
other
Total, other adverse events
0 / 35
serious
Total, serious adverse events
0 / 35

Outcome results

Primary

Shear-Wave Elastography (SWE) Values in kiloPascals (kPa)

Elastography provides a quantitative score of thyroid nodule stiffness that is expected to correlate with the biological nature of the nodule. Mean SWE values, in three planes: traverse plane, sagittal plane and transverse plane with nodule in the center, of all benign lesions were compared with mean SWE values of all malignant lesions on histopathology obtained post surgery.

Time frame: Baseline (Day 0)

Population: All enrolled participants.

ArmMeasureGroupValue (MEAN)Dispersion
Shear-Wave Elastography, Benign LesionsShear-Wave Elastography (SWE) Values in kiloPascals (kPa)Transverse Plane17.50 kPaStandard Deviation 7.65
Shear-Wave Elastography, Benign LesionsShear-Wave Elastography (SWE) Values in kiloPascals (kPa)Sagittal Plane23.64 kPaStandard Deviation 14.86
Shear-Wave Elastography, Benign LesionsShear-Wave Elastography (SWE) Values in kiloPascals (kPa)Transverse Plane with Nodule in the Center17.89 kPaStandard Deviation 9.1
Shear-Wave Elastography, Malignant LesionsShear-Wave Elastography (SWE) Values in kiloPascals (kPa)Transverse Plane31.03 kPaStandard Deviation 13.54
Shear-Wave Elastography, Malignant LesionsShear-Wave Elastography (SWE) Values in kiloPascals (kPa)Sagittal Plane32.14 kPaStandard Deviation 11.98
Shear-Wave Elastography, Malignant LesionsShear-Wave Elastography (SWE) Values in kiloPascals (kPa)Transverse Plane with Nodule in the Center33.80 kPaStandard Deviation 12.5

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026